Twenty Years of Subcutaneous Interferon-Beta-1a for Multiple Sclerosis: Contemporary Perspectives

Abstract Multiple sclerosis (MS) is a chronic, progressive, inflammatory disorder of the central nervous system. Relapsing–remitting MS (RRMS), the most common form of the disease, is characterized by transient neurological dysfunction with concurrent accumulation of disability. Over the past three...

Full description

Bibliographic Details

Published in:	Neurology and Therapy
Main Authors:	Mark S. Freedman, Patricia K. Coyle, Kerstin Hellwig, Barry Singer, Daniel Wynn, Bianca Weinstock-Guttman, Silva Markovic-Plese, Andrew Galazka, Fernando Dangond, Julie Korich, Anthony T. Reder
Format:	Article
Language:	English
Published:	Adis, Springer Healthcare 2024-01-01
Subjects:	Disease-modifying therapies Interferons Interferon-beta-1a Interferon-β-1a for subcutaneous injection Multiple sclerosis Relapsing–remitting multiple sclerosis
Online Access:	https://doi.org/10.1007/s40120-023-00565-7